Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-09-27

FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin's lisinopril and hydrochlorothiazide as a generic fixed-dose combination for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisinopril and Hydrochlorothiazide (Lisinopril and Hydrochlorothiazide)

Snippet

ORIG AP for LISINOPRIL AND HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE)